Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

GE HealthCare has announced a leadership transition for its China operations, with Will Song to succeed Yihao Zhang as new ...

Wuxi AppTec was founded in 2000 by Chief Executive Ge Li, a doctoral graduate in organic chemistry from Columbia University. The contract drugmaker and its affiliates have partnered with companies ...

WuXi AppTec Co., Ltd. provides an integrated pharmaceutical ... The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 an ...

Yihao Zhang, GE HealthCare’s president and CEO for China, plans to retire, effective July 1. The company picked Will Song, a ...

Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...

and Wuxi; as well as establishing new sites in Shenzhen and Chengdu. "GE HealthCare announces Will Song as new president and CEO in China" was originally created and published by Medical Device ...

Chinese electric-car maker Li Auto and pharmaceutical company WuXi Apptec will join the Hang Seng Index as new constituents next month, according to the latest quarterly review by Hong Kong’s ...